Bluebird bio Acquired: A New Era in Gene Therapy Under the leadership of private equity firms Carlyle and SK Capital, bluebird bio embarks on a strategic shift led by CEO David Meek. The emphasis is on expanding access, enhancing manufacturing … Continue reading Bluebird bio Acquired: A New Era in Gene Therapy